ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis

Clinical trial NCT06775860 · RECRUITING

Trial details

NCT number: NCT06775860
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2024-11-14
Primary completion: 2026-11-25
Enrollment: 552

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.